Age-related changes in aortic valve hemostatic protein regulation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 1, 2014, Pages 72-80

  Balaoing, Liezl R ^a   Post, Allison D ^a   Liu, Huiwen ^a   Minn, Kyung Taeck ^a   Grande Allen, K Jane ^a  

^a Rice University   (United States)

Author keywords

Aging; Aortic valve; Endothelial cells; Hemostasis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; DISINTEGRIN; ELASTIN; HEMOSTATIC AGENT; HISTAMINE; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; CALCIFICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEART VALVE REPLACEMENT; HEMOSTASIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; TISSUE ENGINEERING;

EID: 84891836130     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301936     Document Type: Article

References (44)

1. Roger VL, Go AS, Lloyd-Jones DM, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation. 2011;123:e18-e209
2. Hakuno D, Kimura N, Yoshioka M, Fukuda K. Molecular mechanisms underlying the onset of degenerative aortic valve disease. J Mol Med (Berl). 2009;87:17-24
3. Leask RL, Jain N, Butany J. Endothelium and valvular diseases of the heart. Microsc Res Tech. 2003;60:129-137
4. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. 2011;73:29-46
5. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet. 2006;368:1005-1011
6. Schoen FJ. Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering. Circulation. 2008;118:1864-1880
7. Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 2004;10:1725-1736
8. Roosens B, Bala G, Droogmans S, Hostens J, Somja J, Delvenne E, Schiettecatte J, Delvenne P, Lahoutte T, Van Camp G, Cosyns B. Occurrence of cardiovascular calcifications in normal, aging rats. Exp Gerontol. 2012;47:614-619
9. Stephens EH, Saltarrelli JG, Baggett LS, Nandi I, Kuo JJ, Davis AR, Olmsted-Davis EA, Reardon MJ, Morrisett JD, Grande-Allen KJ. Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovasc Pathol. 2011;20:334-342
10. Stephens EH, de Jonge N, McNeill MP, Durst CA, Grande-Allen KJ. Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. Tissue Eng Part A. 2010;16:867-878
11. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, pathology, and tissue engineering. Circulation. 2006;113:1344-1352
12. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis. 2004;13:841-847
13. Stephens EH, Post AD, Laucirica DR, Grande-Allen KJ. Perinatal changes in mitral and aortic valve structure and composition. Pediatr Dev Pathol. 2010;13:447-458
14. Stephens EH, Grande-Allen KJ. Age-related changes in collagen synthesis and turnover in porcine heart valves. J Heart Valve Dis. 2007;16:672-682
15. Stephens EH, Chu CK, Grande-Allen KJ. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve. Acta Biomater. 2008;4:1148-1160
16. Lin SL, Liu CP, Young ST, Lin M, Chiou CW. Age-related changes in aortic valve with emphasis on the relation between pressure loading and thickened leaflets of the aortic valves. Int J Cardiol. 2005;103:272-279
17. Mohler ER 3rd. Mechanisms of aortic valve calcification. Am J Cardiol. 2004;94:1396-402, A6
18. Butcher JT, Penrod AM, García AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004;24:1429-1434
19. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: Effects of steady shear stress. Tissue Eng. 2006;12:905-915
20. Butcher JT, Tressel S, Johnson T, Turner D, Sorescu G, Jo H, Nerem RM. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: Influence of shear stress. Arterioscler Thromb Vasc Biol. 2006;26:69-77
21. Simmons CA, Grant GR, Manduchi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res. 2005;96:792-799
22. Young EW, Wheeler AR, Simmons CA. Matrix-dependent adhesion of vascular and valvular endothelial cells in microfluidic channels. Lab Chip. 2007;7:1759-1766
23. Bischoff J, Aikawa E. Progenitor cells confer plasticity to cardiac valve endothelium. J Cardiovasc Transl Res. 2011;4:710-719
24. Armstrong EJ, Bischoff J. Heart valve development: Endothelial cell signaling and differentiation. Circ Res. 2004;95:459-470
25. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarathchandra P, Taylor PM, Yoganathan AP, Chester AH. Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol. 2009;53:1448-1455
26. Merryman WD. Mechano-potential etiologies of aortic valve disease. J Biomech. 2010;43:87-92
27. Simmons CA. Aortic valve mechanics: An emerging role for the endothelium. J Am Coll Cardiol. 2009;53:1456-1458
28. Widmaier EP, Raff H, Keving ST. Vander's Human Physiology: The Mechanisms of Body Function. 11th ed. Boston, MA: McGraw-Hill Higher Education; 2006:770
29. Li S, Henry JJ. Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng. 2011;13:451-475
30. Pearson JD. Endothelial cell function and thrombosis. Baillieres Best Pract Res Clin Haematol. 1999;12:329-341
31. Federico S, Grillo A, La Rosa G, Giaquinta G, Herzog W. A transversely isotropic, transversely homogeneous microstructural-statistical model of articular cartilage. J Biomech. 2005;38:2008-2018
32. Federico S, Herzog W. On the anisotropy and inhomogeneity of permeability in articular cartilage. Biomech Model Mechanobiol. 2008;7:367-378
33. Mari D, Coppola R, Provenzano R. Hemostasis factors and aging. Exp Gerontol. 2008;43:66-73
34. van den Burg PJ, Hospers JE, Mosterd WL, Bouma BN, Huisveld IA. Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol. 2000;88:1558-1564
35. Gharacholou SM, Becker RC. Hemostasis and thrombosis in older adults. J Thromb Thrombolysis. 2009;27:249-251
36. Cruz MA, Yuan H, Lee JR, Wise RJ, Handin RI. Interaction of the von Willebrand Factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem. 1995;270:10822-10827
37. Turner NA, Nolasco L, Ruggeri ZM, Moake JL. Endothelial cell ADAMTS-13 and VWF: Production, release, and VWF string cleavage. Blood. 2009;114:5102-5111
38. Russmann S, Gohlke-Bärwolf C, Jähnchen E, Trenk D, Roskamm H. Age-dependent differences in the anticoagulant effect of phenprocoumon in patients after heart valve surgery. Eur J Clin Pharmacol. 1997;52:31-35
39. McIntyre TM, Zimmerman GA, Satoh K, Prescott SM. Cultured endothelial cells synthesize both platelet-Activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest. 1985;76:271-280
40. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood. 2004;103:4150-4156
41. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB. Histamine induces interleukin-8 secretion by endothelial cells. Blood. 1994;84:2229-2233
42. Rand JH, Badimon L, Gordon RE, Uson RR, Fuster V. Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location. Arterioscler Thromb Vasc Biol. 1987;7:287-291
43. Royo T, Martínez-González J, Vilahur G, Badimon L. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells. Atherosclerosis. 2003;167:55-63
44. Turner N, Nolasco L, Moake J. Generation and breakdown of soluble ultralarge von Willebrand factor multimers. Semin Thromb Hemost. 2012;38:38-46